HealthCare Global Enterprises Ltd Rights Issue
Rights issue details — issue price, ratio, record date and full review
Issue Price
TBA
Ratio
—
Record Date
02 Mar 2026
Open Date
02 Mar 2026
Close Date
02 Mar 2026
Status
closed
About this Rights Issue
HealthCare Global Enterprises Ltd has announced a rights issue. The record date is 02 Mar 2026; the subscription window opens on 02 Mar 2026 and closes on 02 Mar 2026. A rights issue offers existing shareholders the right to subscribe to additional shares in proportion to their existing holding, typically at a discount to the prevailing market price. Shareholders can either subscribe or renounce their rights (sell the rights entitlement to other investors in the open market).
Frequently Asked Questions
What is the HealthCare Global Enterprises Ltd rights issue price?
The issue price will be disclosed in the rights offer document.
What is the rights ratio?
The ratio will be disclosed by the company before the record date.
Can I sell my rights entitlement instead of subscribing?
Yes. Rights entitlements (REs) trade separately on the exchange between the rights opening date and a few days before the closing date. Shareholders who do not want to subscribe can sell the REs in the open market and realise cash value.
What happens if I don't act?
If you neither subscribe nor sell the rights entitlement, the rights lapse and you forfeit the discount. Your existing shareholding remains intact but its percentage in the company is diluted.
Is a rights issue dilutive?
For shareholders who do not subscribe, yes — their percentage holding declines. For those who subscribe in full to their entitlement, the percentage holding is preserved.
Other Recent Rights Issues
| Company | Price | Ratio | Status |
|---|---|---|---|
| Jaykay Enterprises Ltd | — | — | closed |
| NCL Research & Financial Services Ltd | — | — | closed |
| Ratnaveer Precision Engineering Ltd | — | — | closed |
| Quint Digital Ltd | — | — | closed |
| Ducon Infratechnologies Ltd | — | — | closed |
| Esaar India Ltd | — | — | closed |
Disclaimer: This information is for educational purposes only and is not investment advice. Read the rights offer document carefully and consult a SEBI-registered investment advisor before subscribing.